Skip to main content
. 2012 Oct 8;14(6):864–869. doi: 10.1038/aja.2012.101

Table 2. Genotype and allele frequencies of the HIF1A polymorphisms among the PCa cases and controls.

Polymorphisms Cases (n=662) Controls (n=716) Pa Adjusted OR (95%CI)b
  n % n %    
HIF1A rs11549465            
CC 612 92.5 659 92.0 0.302 1.00 (reference)
CT 48 7.2 57 8.0   0.91 (0.61–1.37)
TT 2 0.3 0 0.0  
CT+TT 50 7.5 57 8.0 0.708 0.95 (0.64–1.42)
C 1272 96.1 1375 96.0 0.943  
T 52 3.9 57 4.0    
Ptrend         0.943  
HIF1A rs11549467            
GG 614 92.8 685 95.7 0.048 1.00 (reference)
GA 47 7.0 31 4.3   1.66 (1.04–2.67)
AA 1 0.2 0 0  
GA+AA 48 7.2 31 4.3 0.020 1.70 (1.06–2.72)
G 1275 96.3 1401 97.8 0.281  
A 49 3.7 31 2.2    
Ptrend         0.016  
HIF1A rs2057482            
CC 418 63.1 428 59.8 0.258 1.00 (reference)
CT 212 32.0 241 33.7   1.31 (0.80–2.15)
TT 32 4.8 47 6.6   1.44 (0.90–2.32)
CT+TT 244 36.9 288 40.2 0.200 1.40 (0.87–2.31)
C 1048 79.2 1097 76.6 0.108  
T 276 20.8 335 23.4    
Ptrend         0.116  

Abbreviations: CI, confidence interval; OR, odds ratio; PCa, prostate cancer.

a

Two-sided χ2 test for either genotype distributions or allele frequencies between the cases and controls.

b

Adjusted for age, smoking, drinking status and family history of cancer in logistic regression model.